Details for Patent: 10,449,159
✉ Email this page to a colleague
Which drugs does patent 10,449,159 protect, and when does it expire?
Patent 10,449,159 protects ADHANSIA XR and is included in one NDA.
This patent has thirty-three patent family members in seventeen countries.
Summary for Patent: 10,449,159
Title: | Methods and compositions particularly for treatment of attention deficit disorder |
Abstract: | There is described, inter alia, a coated bead comprising: (a) a granule; (b) a first layer coated over the granule, the first layer comprising a first amount of an active pharmaceutical ingredient comprising a central nervous system stimulant; and (c) a second layer coated over the first layer, the second layer being present in an amount sufficient to substantially delay release of the active pharmaceutical ingredient in the first layer until after the coated bead reaches a distal intestine portion of a subject to whom the coated bead is administered; and (d) the third layer coated over the second layer, the third layer comprising a second amount of the active pharmaceutical ingredient, the third layer being configured to permit substantially immediate release of the active pharmaceutical ingredient comprised therein. Embodiments related to a solid oral pharmaceutical composition are also described. |
Inventor(s): | Vargas Rincon; Ricardo Alberto (Mississauga, CA), Reiz; Joseph (Markham, CA) |
Assignee: | Purdue Pharma L.P. (Stamford, CT) |
Application Number: | 16/282,876 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 10,449,159
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-001 | Feb 27, 2019 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) | ⤷ Try a Trial | ||||
Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-002 | Feb 27, 2019 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) | ⤷ Try a Trial | ||||
Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-003 | Feb 27, 2019 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) | ⤷ Try a Trial | ||||
Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-004 | Feb 27, 2019 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) | ⤷ Try a Trial | ||||
Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-005 | Feb 27, 2019 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) | ⤷ Try a Trial | ||||
Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-006 | Feb 27, 2019 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,449,159
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 103981 | ⤷ Try a Trial | |||
Australia | 2015337779 | ⤷ Try a Trial | |||
Australia | 2020227021 | ⤷ Try a Trial | |||
Australia | 2020227022 | ⤷ Try a Trial | |||
Brazil | 112017008993 | ⤷ Try a Trial | |||
Canada | 2902911 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |